Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood of severe side effects.
Suzanne Olbricht, MD, Chief of Dermatology at Beth Israel Deaconess Medical Center, shares tips for avoiding sunburns.
A pilot study led by researchers from Tufts University and conducted at the Somerville Council on Aging in Somerville, Mass., translated for the first time the physical activity benefits of the Lifestyle Interventions and Independence for Elders study in a community setting.
New study reveals that a male fruit fly’s decision to court or ignore a female stems from the convergence of motivation, perception and chance that affects the balance of excitatory versus inhibitory signals in the brain to influence decision making. Findings may yield insights about addiction disorders, depression.
In a new study, a team led by clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) surveyed family members and patients with recent ICU experiences about their willingness to speak up about care concerns to medical providers.
A new study out of Beth Israel Deaconess Medical Center reveals that the preventability of readmissions changes over time: readmissions within the first week after discharge are often preventable by the hospital, whereas readmissions later are often related to patients’ difficultly accessing outpatient clinics.
Scientists have defined the structure and key features of a human immune-surveillance protein that guards against cancer and bacterial and viral infections The identification of two human-specific variations in the protein closes a critical knowledge gap in immunology and cancer biology The variations explain why the human protein is more precise and more selective than mammalian forms of the protein and why it targets certain types of DNA but ignores others The findings can inform the design of more precisely targeted immune therapies against cancer and a range of immune-mediated diseases
The Bertarelli Foundation has announced that it is redoubling its investment in this area of research, with a gift of $6.35 million to Harvard Medical School (HMS) to build on the previous successes of the Bertarelli Program in Translational Neuroscience and Neuroengineering.
Researchers discover new clues about a recently identified blood cell condition known as clonal hematopoiesis, implicated in hematologic cancers, cardiovascular illness Surprisingly, the study reveals that inherited genetic variants can drive the condition by fueling additional mutations later in life The findings can help inform ways to gauge disease risk based on specific mutations, develop strategies to avert disease Clonal hematopoiesis is estimated to affect more than 1 in 10 people older than 65
Barbara Kahn, MD, Vice Chair for Research Strategy in the Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC), will receive the 2019 FASEB Excellence in Science Award.
Study findings from a team of scientists led by George C. Tsokos, MD, Chief of the Division of Rheumatology at BIDMC, overturn conventional wisdom about kidney disease.
Research reveals dramatic geographic differences in end-of-life care spending across the United States. Spending variations stemmed from doctors’ beliefs about end-of-life care and style of practice and from availability of health care services. Patient beliefs and preferences did not contribute to spending differences. Health care spending in the last month of life for patients with end-stage cancer in some regions is twice as high as that in other regions. The additional spending is wasteful and possibly harmful.
Providing free fruits and vegetables and limiting sugary drinks in schools could have positive health effects in both the short- and long-term, finds a new Food-PRICE study led by researchers from the Friedman School of Nutrition Science and Policy at Tufts University.
In a new study, published July 6 in The Lancet, a team of researchers led by Beth Israel Deaconess Medical Center's Dan H. Barouch, MD, PhD, in collaboration with Janssen Vaccines & Prevention and other partners, evaluated a series of preventative HIV vaccine regimens in uninfected human volunteers in five countries. In a similarly designed study, Barouch and colleagues tested the same vaccine for its ability to protect rhesus monkeys challenged with an HIV-like virus from infection. The findings showed the vaccines induced robust and comparable immune responses in humans and monkeys and protected monkeys against acquisition of infection.
Researchers at Beth Israel Deaconess Medical Center have found that consuming a broth rich in umami—or savory taste—can cause subtle changes in the brain that promote healthy eating behaviors and food choices, especially in women at risk of obesity.
A “smart” bandage is designed to monitor the condition of chronic wounds and deliver drug treatments to improve chances of healing. While the bandages remain to be assessed in a clinical context, the research is aimed at transforming bandaging from a passive to an active treatment paradigm.
In this study, BIDMC researchers developed a means of tracking the activity of the far-reaching ends of retinal neurons (called boutons) as they deliver visual information to the thalamus, a brain region involved in image processing.
Olin Receives $400,000 Gift for Exploring Innovation in Engineering Education
If you’ve ever had a migraine, you know it’s different from a typical tension headache. Check out these tips from neurologist Sait Ashina, MD, for avoiding common migraine triggers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right